Ingevity Corporation
NGVT
$42.05
$0.912.21%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -17.64% | -16.88% | -13.19% | -11.01% | -2.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.64% | -16.88% | -13.19% | -11.01% | -2.29% |
| Cost of Revenue | -25.71% | -21.24% | -11.65% | -4.84% | 5.75% |
| Gross Profit | 2.97% | -6.24% | -16.70% | -23.82% | -18.20% |
| SG&A Expenses | -11.01% | -9.46% | -12.62% | -17.91% | -11.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.31% | -19.46% | -11.76% | -6.81% | 2.83% |
| Operating Income | 14.15% | -3.66% | -20.12% | -29.34% | -23.64% |
| Income Before Tax | -199.04% | -5,202.97% | -526.89% | -332.47% | -157.05% |
| Income Tax Expenses | -144.41% | -2,140.43% | -468.03% | -293.81% | -162.27% |
| Earnings from Continuing Operations | -215.61% | -7,868.52% | -543.86% | -343.40% | -155.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -215.61% | -7,868.52% | -543.86% | -343.40% | -155.63% |
| EBIT | 14.15% | -3.66% | -20.12% | -29.34% | -23.64% |
| EBITDA | 4.06% | -6.17% | -16.67% | -20.13% | -14.27% |
| EPS Basic | -214.19% | -6,107.70% | -549.72% | -350.18% | -158.18% |
| Normalized Basic EPS | 28.72% | -32.65% | -53.76% | -62.90% | -47.71% |
| EPS Diluted | -212.72% | -5,228.42% | -553.54% | -352.28% | -158.96% |
| Normalized Diluted EPS | 28.93% | -32.37% | -53.44% | -62.72% | -47.58% |
| Average Basic Shares Outstanding | 0.21% | -0.50% | -1.37% | -2.53% | -3.88% |
| Average Diluted Shares Outstanding | 0.34% | -0.81% | -2.08% | -3.20% | -4.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |